Adoptive Immune Transfer in the Functional Cure of Chronic Hepatitis B: Insights from Hematopoietic Stem Cell Transplantation
Achieving a functional cure for chronic hepatitis B remains challenging, primarily due to the inability to reconstitute effective host immune responses against the virus. The unexpected functional cure of chronic hepatitis B following allogeneic hematopoietic stem cell transplantation provides a unique proof-of-principle model for immune-mediated HBsAg clearance. This review aims to elucidate that the core mechanism underlying hematopoietic stem cell transplantation-mediated HBsAg clearance lies in “adoptive immune transfer”, and to explore design principles and future directions for modern cell-based immunotherapies based on this mechanism. We reviewed available case reports and meta-analytic evidence, acknowledging their limitations, and dissected the immunological mechanisms by which donor-derived hepatitis B virus-specific T and B cells may jointly reconstitute adaptive immunity and break host immune tolerance. We then comparatively evaluated the technical characteristics and limitations of chimeric antigen receptor T cell therapy and T-cell receptor-engineered T-cell therapy. Current engineered T-cell therapies, while translating the core principle of adoptive transfer, exhibit fundamental limitations including monoclonal specificity, inability to remodel the host microenvironment, and absence of durable humoral reconstitution. A broader functional-cure strategy may require adopting the paradigm of synergy and systemic immune reshaping exemplified by hematopoietic stem cell transplantation. Future strategies should develop temporally optimized, multilayered combination therapies, offering a possible pathway for next-generation therapeutics capable of systemically rebuilding antiviral immunity.
Authors
- Jia-Rui Zheng (ORCID: https://orcid.org/0000-0003-0202-7488)
- Xin-kun Liu
- Lin-Xiang Huang (ORCID: https://orcid.org/0000-0001-5140-6148)
- Bo Feng (ORCID: https://orcid.org/0000-0001-5084-6715)
- Yan-di Xie
- He Ma
Publication Details
- Journal
- Journal of Clinical and Translational Hepatology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.14218/jcth.2026.00549
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Peking University